Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Presentation Icons
CME
CME
Non-CME
Non-CME
In Person
In Person
On Demand
On Demand
Live Stream
Live Stream
Active Learning
Active Learning
Choose Rheum
Choose Rheum
Emerging Investigator Awardee
Emerging Investigator Awardee

Poster Session

Scleroderma

Poster Session A

Session: (0671–0710) Systemic Sclerosis & Related Disorders – Clinical Poster I

0680: Altered Mirna Patterns of Peripheral Blood Mononuclear Cells Show Correlations with Pulmonary Manifestations of Systemic Sclerosis

Sunday, October 26, 2025
10:30 AM - 12:30 PM Central Time
Location: Hall F1

    Abstract Poster Presenter(s)

  • ZS

    Zoltan Szekanecz, MD, PhD

    University of Debrecen
    Debrecen, Hungary

    Disclosure(s): AbbVie/Abbott: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Berlin Chemie: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Eli Lilly: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Gedeon Richter: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Grant/Research Support (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing)


Background/Purpose: Systemic sclerosis (SSc) is an autoimmune rheumatic and musculoskeletal disease (RMD) with a high mortality. Epigenetic factors, such as miRNAs might play an important role in the pathogenesis of SSc. In this cross-sectional study we assessed miRNA in SSc and associated miRNA expression with disease-related organ manifestations.

Methods: We investigated the miRNA profiles of 52 SSc patients (42 women and 10 men; mean age: 59.1 years (range: 33-76 years). Anticoagulated blood samples were taken from SSc patients, as well as age- and gender-matched healthy controls. Peripheral blood mononuclear cells (PBMC) were isolated on a Ficoll gradient, stored in TRIzol at -20°C until use. Total RNA was purified. Sequencing of miRNAs was performed using high-throughput, new generation (Illumina) sequencing, and an established miRNA library.

Results: Altogether 58 miRNAs showed significantly differential expression in SSc patients compared to controls. Among these miRNAs, 34 were significantly upregulated and 24 downregulated. Out of the differentially expressed miRNAs, 9 upregulated (let-7e-3p, miR-16-1-3p, miR-16-2-3p, miR-27a-5p, miR-34c-5p, miR-92a-1-5p, miR-130b-5p, miR-143-5p, miR-183-5p) and 8 downregulated miRNAs (miR-7-1-3p, miR-17-5p, miR-20a-5p, miR-30b-5p, miR-106a-5p, miR-151a-5p, miR-320b és miR-335-5p) had previously been described in the literature. Thus, the differential expression of further 41 (25 upregulated and 16 downregulated) miRNAs is a novel finding. When comparing SSc patients with (n=34) and without (n=18) interstitial lung disease (ILD)/pulmonary fibrosis, 4 miRNAs (miR-210-3p, miR-222-3p, miR-379-5p, miR-3935-5p) showed elevated, while 4 miRNAs (miR-125a-5p, miR-199b-5p, miR-941, miR-1226-3p) showed decreased expression levels in patients with SSc-ILD. Some of the differentially expressed miRNAs are associated with TGFβ signalling pathways.

Conclusion: SSc is associated with differential expression of several miRNAs. The up- or down-regulated expression of some miRNAs might be associated with SSc-ILD. Thus, miRNAs might have an important role in the molecular pathogenesis of SSc, as well as SSc-ILD and some of them might serve as therapeutic targets as well.